Skip to main content
. Author manuscript; available in PMC: 2017 Jan 3.
Published in final edited form as: Liver Transpl. 2016 Jan;22(1):24–33. doi: 10.1002/lt.24366

Table 5.

Anemia management

SMV/SOF
(n=119)
SMV/SOF/RBV
(n=32)
Total
(n=151)
AE Anemia, n (%) 4 (3.4) 13 (40.6) 17 (11.3)

SAE Anemia, n (%) 1 (0.8) 0 (0.0) 1 (0.7)

Hemoglobin change, delta mean (range) −0.1 (−4.9,+3.1) −1.2 (−6.9,+4.1) −0.4 (−6.9,+4.1)

Anemia management, n (%)
  Ribavirin dose reduction/interruption 0 (0.0) 8 (25.0) 8 (5.3)
  Epoietin use 0 (0.0) 5 (15.6) 5 (3.3)
  Blood transfusion 2 (1.7) 3 (9.4) 5 (3.3)
  Ribavirin discontinuation 0 (0.0) 1 (3.1) 1 (0.7)